Melatonin use among children, adolescents, and young adults: a Danish nationwide drug utilization study
- PMID: 35792937
- DOI: 10.1007/s00787-022-02035-1
Melatonin use among children, adolescents, and young adults: a Danish nationwide drug utilization study
Abstract
We aimed to provide a detailed description of the use of melatonin in Danish children, adolescents, and young adults during 2012-2019. We identified melatonin users 0-24 years of age (n = 43,652; median age 16 years) via the Danish nationwide health registers. Melatonin is a prescription drug in Denmark. The incidence of melatonin use increased from 2.4 to 3.9/1000 person-years during 2012 to 2019. Among 6,557 incident users in 2019, 53% filled only a single prescription within the first 6 months. Long-term use was most common among the younger age groups, with 17% of 5-9-year-olds and 14% of 10-13-year-olds being in continued treatment (no treatment breaks) 12 months after their first melatonin prescription. Disregarding treatment breaks, 3 in 10 were using melatonin 12 months after their first melatonin prescription and this proportion was also highest among 5-9-year-olds (63%) and 10-13-year-olds (51%). Psychopathology was common among melatonin users with 75% registered with either a psychiatric disorder diagnosis (54%), a filled prescription for another psychotropic (58%), or a contact to a private practice psychiatrist (15%) within ± 12 months of treatment initiation. General practitioners authorized melatonin prescriptions to almost half of all new users (48%), while psychiatric specialists authorized 37% of first prescriptions. In conclusion, the incidence of melatonin use increased in Denmark from 2012 to 2019. A substantial proportion of users had concurrent psychopathology most likely explaining their use of melatonin. Long-term melatonin use was more common among the youngest age groups, which should be a focus of interest due to limited safety data.
Keywords: Adolescent; Child; Drug utilization study; Melatonin; Register-based cohort study.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
References
-
- Calhoun SL, Fernandez-Mendoza J, Vgontzas AN et al (2014) Prevalence of insomnia symptoms in a general population sample of young children and preadolescents: gender effects. Sleep Med 15:91–95. https://doi.org/10.1016/j.sleep.2013.08.787 - DOI - PubMed
-
- Quine L (2001) Sleep problems in primary school children: comparison between mainstream and special school children. Child Care Health Dev 27:201–221. https://doi.org/10.1046/j.1365-2214.2001.00213.x - DOI - PubMed
-
- Riemann D, Baglioni C, Bassetti C et al (2017) European guideline for the diagnosis and treatment of insomnia. J Sleep Res 26:675–700. https://doi.org/10.1111/jsr.12594 - DOI - PubMed
-
- Astill RG, Van der Heijden KB, Van Ijzendoorn MH, Van Someren EJW (2012) Sleep, cognition, and behavioral problems in school-age children: a century of research meta-analyzed. Psychol Bull 138:1109–1138. https://doi.org/10.1037/a0028204 - DOI - PubMed
-
- Liu R, Dong H, Wang Y et al (2021) Sleep problems of children with autism may independently affect parental quality of life. Child Psychiatry Hum Dev 52:488–499. https://doi.org/10.1007/s10578-020-01035-z - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
